A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy

Metabolically Labile Fumarate Esters Impart Kinetic Selectivity to Irreversible Inhibitors

(2016) Balyn W. Zaro et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

(2016) Ulf Schulze-Topphoff et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties

(2015) Irida Kastrati et al.   BMC CANCER

Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein

(2015) Irida Kastrati et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis

(2015) Yuechao Zhao et al.   Science Translational Medicine

ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays

(2014) Camilo Guzmán et al.   PLoS One

Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network

(2014) Jerome C Nwachukwu et al.   eLife

Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)

(2012) Makoto Kubo et al.   BREAST CANCER RESEARCH AND TREATMENT

Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis

(2012) Dionne P. Robinson et al.   HORMONES AND BEHAVIOR

Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers

(2012) Sarah C. Baumgarten et al.   MOLECULAR ENDOCRINOLOGY

The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications

(2011) Marco A. Velasco-Velázquez et al.   AMERICAN JOURNAL OF PATHOLOGY

CBP Mediates NF- B-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter

(2011) M. Pradhan et al.   MOLECULAR AND CELLULAR BIOLOGY

The resurgence of covalent drugs

(2011) Juswinder Singh et al.   NATURE REVIEWS DRUG DISCOVERY

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

Nuclear NF- B/p65 expression and response to neoadjuvant chemotherapy in breast cancer

(2010) R. L. Jones et al.   JOURNAL OF CLINICAL PATHOLOGY

Positive Cross-Talk between Estrogen Receptor and NF- B in Breast Cancer

(2009) J. Frasor et al.   CANCER RESEARCH

The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies

(2009) Brett G. Hollier et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Association of reactive oxygen species levels and radioresistance in cancer stem cells

(2009) Maximilian Diehn et al.   NATURE

Cancer stem cells: implications for the progression and treatment of metastatic disease

(2008) A.K Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses

(2008) Kendall W Nettles et al.   Nature Chemical Biology